Dolmans Marie-Madeleine, Hossay Camille, Nguyen Thu Yen Thi, Poirot Catherine
Gynecology Research Unit, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Av. Mounier 52, 1200 Brussels, Belgium.
Department of Gynecology, Cliniques Universitaires Saint-Luc, Av. Hippocrate 10, 1200 Brussels, Belgium.
J Clin Med. 2021 Nov 11;10(22):5247. doi: 10.3390/jcm10225247.
Chemotherapy, pelvic radiotherapy and ovarian surgery have known gonadotoxic effects that can lead to endocrine dysfunction, cessation of ovarian endocrine activity and early depletion of the ovarian reserve, causing a risk for future fertility problems, even in children. Important determinants of this risk are the patient's age and ovarian reserve, type of treatment and dose. When the risk of premature ovarian insufficiency is high, fertility preservation strategies must be offered to the patient. Furthermore, fertility preservation may sometimes be needed in conditions other than cancer, such as in non-malignant diseases or in patients seeking fertility preservation for personal reasons. Oocyte and/or embryo vitrification and ovarian tissue cryopreservation are the two methods currently endorsed by the American Society for Reproductive Medicine, yielding encouraging results in terms of pregnancy and live birth rates. The choice of one technique above the other depends mostly on the age and pubertal status of the patient, and personal and medical circumstances. This review focuses on the available fertility preservation techniques, their appropriateness according to patient age and their efficacy in terms of pregnancy and live birth rates.
化疗、盆腔放疗和卵巢手术都具有已知的性腺毒性作用,可导致内分泌功能障碍、卵巢内分泌活动停止以及卵巢储备过早耗竭,即使对儿童而言,也会造成未来生育问题的风险。这种风险的重要决定因素包括患者年龄、卵巢储备、治疗类型和剂量。当卵巢早衰风险较高时,必须向患者提供生育力保存策略。此外,有时在癌症以外的情况下也可能需要进行生育力保存,例如在非恶性疾病中或出于个人原因寻求生育力保存的患者。卵母细胞和/或胚胎玻璃化冷冻以及卵巢组织冷冻保存是目前美国生殖医学学会认可的两种方法,在妊娠率和活产率方面取得了令人鼓舞的结果。选择其中一种技术而非另一种技术主要取决于患者的年龄和青春期状态以及个人和医疗情况。本综述重点关注现有的生育力保存技术、根据患者年龄的适用性以及在妊娠率和活产率方面的效果。